PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare lung condition in japanese patients
Disease control CompletedThis study tested a drug called sotatercept (MK-7962) added to standard treatment for Japanese adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes the heart work harder. 46 participants received the drug to see if it improve…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
Could a natural hormone ease a rare lung disease?
Disease control CompletedThis study tested whether the hormone DHEA can improve heart function in people with pulmonary arterial hypertension (PAH), a condition where high blood pressure strains the heart. Twenty-six adults took DHEA or a placebo in two 18-week periods, with a washout in between. The mai…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
Nerve-Burning procedure shows promise for rare lung condition
Disease control CompletedThis study tested a procedure called pulmonary artery denervation (PADN) for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. 128 adults received either the real procedure or a sham (fake) operation. The main goal was to s…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
New inhaled treatment shows promise for rare lung disease
Disease control CompletedThis study tested an inhaled medication called treprostinil palmitil in 102 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe and move. The goal was to see if the drug could lower resistance in lung bloo…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New hope for rare lung disease: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called ACT-293987 in 43 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The trial first checked how a single dose affects blood flow in the lungs, then compared the drug to a placebo…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Actelion • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New inhaled drug shows promise for lung disease patients
Disease control CompletedThis study tested an inhaled medication called seralutinib in 390 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe and exercise. The goal was to see if the drug helps people walk farther in six minutes and delays the diseas…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New PAH drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested an investigational drug called KER-012 in 113 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. Participants took KER-012 or a placebo alongside their usual PAH medications. The goal was to see if KER-012 …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Keros Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Lung scans reveal CS1 Drug's impact on tiny arteries in PAH patients
Disease control CompletedThis study looked at how the drug CS1 changes small blood vessels in the lungs of people with pulmonary arterial hypertension (PAH). Seven participants received CS1 and had special lung scans at the start and after 12 months. The goal was to see if CS1 could improve blood vessel …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Could a common diabetes pill help people with rare lung disease breathe easier?
Disease control CompletedThis study tested the drug dapagliflozin, usually used for diabetes, in 52 adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. The goal was to see if it could improve exercise capacity and heart function. Participants took the drug …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Mads Ersbøll • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug shows promise for better heart function in PAH patients
Disease control CompletedThis study tested whether the drug sotatercept, given for 36 weeks, can improve how the heart and lungs work during exercise in people with pulmonary arterial hypertension (PAH). Thirty adults with PAH took part. The main goal was to see if the drug helps the heart pump blood mor…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New inhaled treatment shows promise for rare lung condition
Disease control CompletedThis study tested an inhaled medication called RT234 in 14 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe. The goal was to see if the drug could lower lung blood pressure and check for side effects li…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Heart drug shows promise in small Right-Failure trial
Disease control CompletedThis study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it safely reduces stress on the right side of the heart and improves heart function. Participants took either spironolactone or a placebo, and researchers measure…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Inhaled drug shows promise for exercise in lung disease patients
Disease control CompletedThis study looked at how an inhaled medication called treprostinil affects exercise ability in people with pulmonary hypertension caused by interstitial lung disease. 29 participants took the drug for 3 months. Researchers measured heart function and breathing efficiency during e…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for kids with rare lung condition: drug shows promise in small trial
Disease control CompletedThis study tested a drug called macitentan in 7 Japanese children (ages 3 months to 15 years) with pulmonary arterial hypertension, a condition where blood pressure in the lungs is dangerously high. The goal was to see if the drug improves blood flow through the lungs after 24 we…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New PAH pill aims to keep patients out of hospital
Disease control CompletedThis study tested an experimental pill called ralinepag for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work too hard. About 687 adults with PAH took either ralinepag or a placebo on top of their usual treatments. The goal was …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New hope for kids with rare lung condition: drug shows promise in major trial
Disease control CompletedThis study tested a drug called macitentan in 165 children with pulmonary arterial hypertension (PAH), a serious condition where blood pressure in the lungs is too high. The goal was to see how the drug works in the body, if it is safe, and if it helps control the disease better …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New PAH pill shows promise in delaying disease worsening
Disease control CompletedThis study tested a drug called selexipag in over 1,100 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The goal was to see if selexipag could delay the first time a patient's condition got worse or led to death, compared…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New dosing strategy for PAH drug under study
Disease control CompletedThis study looked at two ways of giving the drug sotatercept to 164 adults with pulmonary arterial hypertension (PAH), a condition where lung blood vessels narrow, making it hard to breathe. Researchers compared a standard weight-based dose to a simpler weight-banded approach to …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced PAH: drug delays death and hospitalization
Disease control CompletedThis study tested a drug called sotatercept in 173 people with severe pulmonary arterial hypertension (PAH) who were at high risk of dying. Participants received either the drug or a placebo on top of their usual treatments. The goal was to see if the drug could delay death, the …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Simple breathing exercises boost exercise capacity in lung hypertension patients
Symptom relief CompletedThis study tested whether 8 weeks of inspiratory muscle training (exercises to strengthen breathing muscles) could help people with pulmonary hypertension. 32 adults with the condition participated. The goal was to see if the training improved exercise capacity and breathing resp…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Federal University of São Paulo • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC
-
Oxygen no better than air for exercise in lung disease patients?
Symptom relief CompletedThis study looked at whether people with pulmonary vascular disease (problems with blood vessels in the lungs) need extra oxygen during exercise to walk as far. 40 adults with this condition walked on both room air and low-flow oxygen to compare distances. The goal was to see if …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New drug shows promise for easier breathing during exercise in PAH patients
Symptom relief CompletedThis study looked at whether a single dose of an inhaled drug called RT234 can safely help people with pulmonary arterial hypertension (PAH) exercise longer and feel less short of breath. 42 adults with PAH took the drug and then did exercise tests. The main goals were to check s…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Heart scans could predict survival in lung disease patients
Knowledge-focused CompletedThis study looked at 112 people with pulmonary hypertension (high blood pressure in the lungs) to see if heart MRI scans could better predict who needs a transplant or may die. Researchers compared MRI results with standard heart catheterization tests. The goal was to improve how…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated May 26, 2026 09:07 UTC
-
Can carnitine help PAH patients? small study investigates
Knowledge-focused CompletedThis study looked at whether people with pulmonary arterial hypertension (PAH) have low carnitine levels and if taking carnitine supplements could help. Ten adults with PAH completed the study, which measured carnitine in their diet and blood over several weeks. The goal was to g…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 09:06 UTC
-
Breathing in xenon: new MRI technique could reveal hidden lung changes in PAH
Knowledge-focused CompletedThis study tested a special MRI technique using inhaled xenon gas to see how well the lungs exchange gas in people with pulmonary arterial hypertension (PAH). Ten adults with PAH had four MRI scans over 18 weeks while starting or continuing treatment. The goal was to find new ima…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 09:04 UTC
-
Can a heart drug spray help lung blood vessels?
Knowledge-focused CompletedThis study looked at whether breathing in nitroglycerin (a medicine that opens blood vessels) is safe and effective for people with pulmonary arterial hypertension (PAH), a condition where lung blood vessels narrow. Twenty adults with PAH took part. The goal was to see if the spr…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Mansoura University • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC
-
Pollution danger: new study links dirty air to pregnancy risks in heart patients
Knowledge-focused CompletedThis study looked at 1,200 pregnant women with pulmonary hypertension (high blood pressure in the lungs) to see if long-term exposure to air pollution raised their risk of serious problems like heart failure or death. Researchers reviewed medical records from 2013 to 2022. The go…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Wei Huang • Aim: Knowledge-focused
Last updated May 26, 2026 08:20 UTC
-
Healthy volunteers help uncover drug combo safety for lung condition
Knowledge-focused CompletedThis study looked at how two medicines, BIA 5-1058 and furosemide, affect each other in the body. It involved 44 healthy adults who took the drugs alone and together. The goal was to gather safety and drug-level information to help design future treatments for pulmonary arterial …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Bial - Portela C S.A. • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC
-
New MRI scan could replace invasive heart test for lung patients
Knowledge-focused CompletedThis study looked at whether a special MRI scan (4D Flow) can measure blood flow in the lungs as accurately as the standard invasive test (cardiac catheterization) in people with pulmonary hypertension linked to congenital heart disease. Researchers enrolled 50 patients aged 7 an…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
Immune clues may predict lung blood pressure outcomes
Knowledge-focused CompletedThis study looked at 629 adults with different types of pulmonary arterial hypertension (PAH), including those linked to HIV, heart defects, and connective tissue diseases. Researchers tested blood for antibodies that attack blood vessel and lung cells to see if these immune mark…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:17 UTC